K Health (previously Kang Health) is a company developing a mobile app that uses artificial intelligence to deliver personalized primary care. The company's health information platform gathers information based on individual reported symptoms and provides diagnostics and treatment suggestions, enabling medical practitioners to turn clinical health data into knowledge that can help in managing health.
Founded in 2016 by Adam Singolda (Board Member), Allon Bloch (CEO), Israel Roth (CTO), and Ran Shaul (Chief Product Officer), K Health is based in New York and Tel Aviv. The company has built a global team of doctors and developers to utilize advanced machine learning techniques to turn clinical health data into knowledge that can help you better manage your health.
Since its founding K Health, has received significant funding including backing from prominent New York and Israeli seed investors. The company raised $3.3M in seed funding in November 2016, Mangrove Capital Partners were lead investors.
K Health has since raised a further $94M in Series A, B, and C rounds as well as 2 further Corporate rounds. This includes $25M Series B round in December 2018 and $48M Series C round in February 2020. Investors include Mangrove, 14W, Comcast Ventures, Lerer Hippeau, Primary Ventures, Max Ventures, and The Box Group.
On March 13th, 2020, K Health began offering free virtual primary care for coronavirus questions including unlimited access to U.S. doctors free for 14 days. K Health's platform also offers risk assessment and symptom heat maps.
- Artificial intelligenceTopics related to artificial intelligence.
- COVID-19COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the World Health Organization.